Clostridium Infections
39 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Infections
Narrower: Tetanus 11
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Bezlotoxumab for clostridium infections | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine) for tetanus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DAPTACEL®: DTaP for tetanus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DAPTACEL®. (DTaP), IPOL®., and ActHIB®. for tetanus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine, BK1301) for tetanus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed for tetanus | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DTaP (Diphtheria & Tetanus Toxoids & Acellular Pertussis Adsorbed) for tetanus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DTaP-IPV and ActHIB® for tetanus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| DTaP-IPV combined vaccine for tetanus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Faecal bacteriotherapy (FBT) for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal Microbial Transplantation for clostridium infections | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal microbiota for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 5 |
| Fecal Microbiota Transplant for clostridium infections | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Fecal Microbiota Transplant (FMT) for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal microbiota transplant (Promicrobioma) for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal Microbiota Transplantation (FMT) for clostridium infections | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal Microbiota Transplantation (FMT) + ISOTONIC SODIUM CHLORIDE SOLUTION for clostridium infections | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal microbiota transplantion (FMT) for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal Transplant for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal Virome Transplantation for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fidaxomicin for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fmt for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 3 |
| FMT (Fecal Microbiota Transplantation) for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| FMT-c Lactobacillus for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fresh FMT for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Frozen-and-Thawed FMT for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Healthy donor stool for clostridium infections | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Low Dose FMT Capsule DE for clostridium infections | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| MBK-01 for clostridium infections | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| METRONIDAZOLE + Vancomycin + Loperamide + FECAL MICROBIOTA for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PEDIACEL® and Prevenar® for tetanus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Penn Microbiome Therapy - 001 for clostridium infections | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Penn Microbiome Therapy - 001 + Penn Microbiome Therapy - 002 + Penn Microbiome Therapy - 003 for clostridium infections | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Penn Microbiome Therapy - 002 + Penn Microbiome Therapy - 003 for clostridium infections | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Pentacel®: DTaP-IPV/Hib combined for tetanus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| RBX2660 for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| RBX2660 (microbiota suspension) for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis) for tetanus | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vancomycin for clostridium infections | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.